Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Alicia M Kemble"'
Publikováno v:
PLoS ONE, Vol 15, Iss 3, p e0229850 (2020)
Reducing Amyloid β (Aβ) in the brain is of fundamental importance for advancing the therapeutics for Alzheimer`s disease. The endogenous metallopeptidase neprilysin (NEP) has been identified as one of the key Aβ-degrading enzymes. Delivery of NEP
Externí odkaz:
https://doaj.org/article/aa89271f13884ee2b314a47af6c49151
Autor:
Alicia M. Kemble, Benoit Hornsperger, Iris Ruf, Hans Richter, Jörg Benz, Bernd Kuhn, Dominik Heer, Matthias Wittwer, Britta Engelhardt, Uwe Grether, Ludovic Collin
Publikováno v:
PLoS ONE, Vol 17, Iss 9 (2022)
Chronic inflammation and blood–brain barrier dysfunction are key pathological hallmarks of neurological disorders such as multiple sclerosis, Alzheimer’s disease and Parkinson’s disease. Major drivers of these pathologies include pro-inflammato
Externí odkaz:
https://doaj.org/article/d34faf86a82540f88518f79cdabc62d6
Autor:
Dragana Avramovic, Sébastien A. Archaimbault, Alicia M. Kemble, Sabine Gruener, Mirjana Lazendic, Peter D. Westenskow
Publikováno v:
Biomedicines; Volume 10; Issue 6; Pages: 1404
Diabetic retinopathy (DR) is a microvascular disease of the retina and a serious complication of type I and type II diabetes mellitus. DR affects working-age populations and can cause permanent vision loss if left untreated. The standard of care for
Publikováno v:
PLoS ONE, Vol 15, Iss 3, p e0229850 (2020)
PLoS ONE
PLoS ONE
Reducing Amyloid β (Aβ) in the brain is of fundamental importance for advancing the therapeutics for Alzheimer`s disease. The endogenous metallopeptidase neprilysin (NEP) has been identified as one of the key Aβ-degrading enzymes. Delivery of NEP